Definium Therapeutics, Inc. (DFTX)

SEC filing

Definium Therapeutics, Inc.

DFTX · CIK 1813814

4 · Sep 29, 2026 · Chief Commercial Officer Wiley Matthew T. sold 3,097 Common Shares at $36.57/unit ($113.3K)

Chief Commercial Officer Wiley Matthew T. sold 3,097 Common Shares at $36.57/unit ($113.3K)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.